seed
Stage
1
Investors
About
Oncostellae is a clinical-stage biopharmaceutical company developing proprietary small-molecule drug candidates targeting unmet medical needs in immunology and oncology, with development and commercialization rights licensed to established pharmaceutical companies.
Explore Oncostellae's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.